VENUGOPAL MENON

TitleClinical Assistant Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Pediatrics
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Pfeffer MA, Claggett B, Lewis EF, Granger CB, Køber L, Maggioni AP, Mann D, McMurray JJV, Rouleau JL, Solomon SD, Steg PG, Berwanger O, Cikes M, De Pasquale CG, Fernandez A, Filippatos G, Jering K, Landmesser U, Menon V, Prof Merkely B, Petrie MC, Petrov I, Schou M, Senni M, Sim D, van der Meer P, Lefkowitz M, Zhou Y, Wang Y, Braunwald E. Impact of Sacubitril/Valsartan Versus Ramipril on Total Heart Failure Events in the PARADISE-MI Trial. Circulation. 2021 Nov 19. PMID: 34797725.
      Citations:    Fields:    
    2. Bhatt AS, Berg DD, Bohula EA, Alviar CL, Baird-Zars VM, Barnett CF, Burke JA, Carnicelli AP, Chaudhry SP, Daniels LB, Fang JC, Fordyce CB, Gerber DA, Guo J, Jentzer JC, Katz JN, Keller N, Kontos MC, Lawler PR, Menon V, Metkus TS, Nativi-Nicolau J, Phreaner N, Roswell RO, Sinha SS, Jeffrey Snell R, Solomon MA, Van Diepen S, Morrow DA. De Novo vs Acute-on-Chronic Presentations of Heart Failure-Related Cardiogenic Shock: Insights from the Critical Care Cardiology Trials Network Registry. J Card Fail. 2021 10; 27(10):1073-1081. PMID: 34625127.
      Citations:    Fields:    
    3. Nair R, Johnson M, Kravitz K, Huded C, Rajeswaran J, Anabila M, Blackstone E, Menon V, Lincoff AM, Kapadia S, Khot UN. Characteristics and Outcomes of Early Recurrent Myocardial Infarction After Acute Myocardial Infarction. J Am Heart Assoc. 2021 08 17; 10(16):e019270. PMID: 34333986.
      Citations:    Fields:    Translation:Humans
    4. Kumar A, Zhou L, Huded CP, Moennich LA, Menon V, Puri R, Reed GW, Nair R, Khatri JJ, Krishnaswamy A, Lincoff AM, Ellis SG, Ziada KM, Kapadia SR, Khot UN. Prognostic implications and outcomes of cardiac arrest among contemporary patients with STEMI treated with PCI. Resusc Plus. 2021 Sep; 7:100149. PMID: 34345872.
      Citations:    
    5. Nissen SE, Lincoff AM, Wolski K, Ballantyne CM, Kastelein JJP, Ridker PM, Ray KK, McGuire DK, Mozaffarian D, Koenig W, Davidson MH, Garcia M, Katona BG, Himmelmann A, Loss LE, Poole M, Menon V, Nicholls SJ. Association Between Achieved ?-3 Fatty Acid Levels and Major Adverse Cardiovascular Outcomes in Patients With High Cardiovascular Risk: A Secondary Analysis of the STRENGTH Trial. JAMA Cardiol. 2021 May 16. PMID: 33993205.
      Citations: 2     Fields:    
    6. Henry TD, Tomey MI, Tamis-Holland JE, Thiele H, Rao SV, Menon V, Klein DG, Naka Y, Piña IL, Kapur NK, Dangas GD. Invasive Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Scientific Statement From the American Heart Association. Circulation. 2021 Apr 13; 143(15):e815-e829. PMID: 33657830.
      Citations: 4     Fields:    
    7. Gonzalez MH, Wang Q, Yaranov DM, Albert C, Wolski K, Wagener J, Aggarwal A, Menon V, Jacob M, Tang W, Hsich E, Taylor D, Tong M, Soltesz E, Estep JD, Starling RC, Joyce E. Dynamic Assessment of Pulmonary Artery Pulsatility Index Provides Incremental Risk Assessment for Early Right Ventricular Failure After Left Ventricular Assist Device. J Card Fail. 2021 07; 27(7):777-785. PMID: 33640481.
      Citations:    Fields:    Translation:Humans
    8. Cohen JA, Montgomery RA, Zmaili MA, Rampersad P, Menon V, Tong MZ, Soltesz EG, Weiss AJ. Post-Myocardial Infarction Ventricular Septal Rupture Bridged to Heartmate 3 with an Impella 5.5. Ann Thorac Surg. 2021 09; 112(3):e161-e163. PMID: 33482161.
      Citations:    Fields:    Translation:Humans
    9. Jentzer JC, Burstein B, Van Diepen S, Murphy J, Holmes DR, Bell MR, Barsness GW, Henry TD, Menon V, Rihal CS, Naidu SS, Baran DA. Defining Shock and Preshock for Mortality Risk Stratification in Cardiac Intensive Care Unit Patients. Circ Heart Fail. 2021 01; 14(1):e007678. PMID: 33464952.
      Citations:    Fields:    Translation:Humans
    10. Martyn T, Faulkenberg KD, Albert CL, Il'giovine ZJ, Randhawa VK, Donnellan E, Menon V, Estep JD, Nissen SE, Wilson Tang WH, Starling RC. Acute Hemodynamic Effects of Sacubitril-Valsartan In Heart Failure Patients Receiving Intravenous Vasodilator and Inotropic Therapy. J Card Fail. 2021 03; 27(3):368-372. PMID: 33358957.
      Citations: 1     Fields:    Translation:Humans
    11. Nicholls SJ, Lincoff AM, Garcia M, Bash D, Ballantyne CM, Barter PJ, Davidson MH, Kastelein JJP, Koenig W, McGuire DK, Mozaffarian D, Ridker PM, Ray KK, Katona BG, Himmelmann A, Loss LE, Rensfeldt M, Lundström T, Agrawal R, Menon V, Wolski K, Nissen SE. Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial. JAMA. 2020 12 08; 324(22):2268-2280. PMID: 33190147.
      Citations: 42     Fields:    Translation:Humans
    12. Jentzer JC, Lawler PR, van Diepen S, Henry TD, Menon V, Baran DA, Džavík V, Barsness GW, Holmes DR, Kashani KB. Systemic Inflammatory Response Syndrome Is Associated With Increased Mortality Across the Spectrum of Shock Severity in Cardiac Intensive Care Patients. Circ Cardiovasc Qual Outcomes. 2020 12; 13(12):e006956. PMID: 33280435.
      Citations: 2     Fields:    Translation:Humans
    13. Puri R, Nissen SE, Arsenault BJ, St John J, Riesmeyer JS, Ruotolo G, McErlean E, Menon V, Cho L, Wolski K, Lincoff AM, Nicholls SJ. Effect of C-Reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients With High-Risk Vascular Disease: A Prespecified Secondary Analysis of the ACCELERATE Trial. JAMA Cardiol. 2020 Oct 01; 5(10):1136-1143. PMID: 32639518.
      Citations: 6     Fields:    
    14. Sheng CC, Sahoo D, Dugar S, Prada RA, Wang TKM, Abou Hassan OK, Brennan D, Culver DA, Rajendram P, Duggal A, Lincoff AM, Nissen SE, Menon V, Cremer PC. Canakinumab to reduce deterioration of cardiac and respiratory function in SARS-CoV-2 associated myocardial injury with heightened inflammation (canakinumab in Covid-19 cardiac injury: The three C study). Clin Cardiol. 2020 Oct; 43(10):1055-1063. PMID: 32830894.
      Citations: 18     Fields:    Translation:HumansCTClinical Trials
    15. Kumar A, Huded CP, Zhou L, Krittanawong C, Young LD, Krishnaswamy A, Menon V, Lincoff AM, Ellis SG, Reed GW, Kapadia SR, Khot UN. Implementation of a Comprehensive ST-Elevation Myocardial Infarction Protocol Improves Mortality Among Patients With ST-Elevation Myocardial Infarction and Cardiogenic Shock. Am J Cardiol. 2020 11 01; 134:1-7. PMID: 32933753.
      Citations: 1     Fields:    Translation:Humans
    16. Harb SC, Bhat P, Cremer PC, Wu Y, Cremer LJ, Berger S, Cho L, Menon V, Gulati M, Jaber WA. Prognostic Value of Functional Capacity in Different Exercise Protocols. J Am Heart Assoc. 2020 07 07; 9(13):e015986. PMID: 32578479.
      Citations: 2     Fields:    Translation:Humans
    17. Jentzer JC, Henry TD, Barsness GW, Menon V, Baran DA, Van Diepen S. Influence of cardiac arrest and SCAI shock stage on cardiac intensive care unit mortality. Catheter Cardiovasc Interv. 2020 12; 96(7):1350-1359. PMID: 32180344.
      Citations: 6     Fields:    Translation:Humans
    18. Huded CP, Kapadia SR, Ballout JA, Krishnaswamy A, Ellis SG, Raymond R, Cho L, Simpfendorfer C, Bajzer C, Martin J, Nair R, Lincoff AM, Kravitz K, Menon V, Hantz S, Khot UN. Association of adoption of transradial access for percutaneous coronary intervention in ST elevation myocardial infarction with door-to-balloon time. Catheter Cardiovasc Interv. 2020 08; 96(2):E165-E173. PMID: 32105411.
      Citations: 1     Fields:    Translation:Humans
    19. Menon V, Kumar A, Patel DR, John JS, Wolski KE, McErlean E, Riesmeyer JS, Weerakkody G, Ruotolo G, Cremer PC, Nicholls SJ, Lincoff AM, Nissen SE. Impact of Baseline Glycemic Control on Residual Cardiovascular Risk in Patients With Diabetes Mellitus and High-Risk Vascular Disease Treated With Statin Therapy. J Am Heart Assoc. 2020 01 07; 9(1):e014328. PMID: 31852422.
      Citations: 1     Fields:    Translation:Humans
    20. Shah NP, Wang Q, Wolski KE, Cho L, McErlean E, Ruotolo G, Weerakkody G, Riesmeyer JS, Nicholls SJ, Lincoff AM, Nissen SE, Menon V. The Role of Lipoprotein (a) as a Marker of Residual Risk in Patients With Diabetes and Established Cardiovascular Disease on Optimal Medical Therapy: Post Hoc Analysis of ACCELERATE. Diabetes Care. 2020 02; 43(2):e22-e24. PMID: 31806654.
      Citations:    Fields:    
    21. Kumar A, Patel DR, Brennan DM, Wolski KE, Lincoff AM, Ruotolo G, McErlean E, Weerakkody G, Riesmeyer JS, Nicholls SJ, Nissen SE, Menon V. Plasma Aldosterone Levels Are Not Associated With Cardiovascular Events Among Patients With High-Risk Vascular Disease: Insights From the ACCELERATE Trial. J Am Heart Assoc. 2019 12 03; 8(23):e013790. PMID: 31752637.
      Citations: 1     Fields:    Translation:Humans
    22. Martyn T, Faulkenberg KD, Yaranov DM, Albert CL, Hutchinson C, Menon V, Estep JD, Nissen SE, Tang WHW, Starling RC. Initiation of Angiotensin Receptor-Neprilysin Inhibitor in Heart Failure With Low Cardiac Output. J Am Coll Cardiol. 2019 11 05; 74(18):2326-2327. PMID: 31672191.
      Citations: 1     Fields:    Translation:Humans
    23. Jentzer JC, van Diepen S, Barsness GW, Henry TD, Menon V, Rihal CS, Naidu SS, Baran DA. Cardiogenic Shock Classification to Predict Mortality in the Cardiac Intensive Care Unit. J Am Coll Cardiol. 2019 10 29; 74(17):2117-2128. PMID: 31548097.
      Citations: 40     Fields:    Translation:Humans
    24. Kumar A, Shah NP, Menon V, Nissen SE. Purpura fulminans manifesting with Staphylococcus aureus endocarditis: a case report. Eur Heart J Case Rep. 2019 Jun 01; 3(2). PMID: 31449632.
      Citations:    
    25. Spitzer E, McFadden E, Vranckx P, Garcia-Garcia HM, Seltzer JH, Held C, de Vries T, Menon V, Brown KJ, Soliman OII, Onuma Y, Lopes RD, Stone GW, Cutlip DE, Serruys PW. Critical Appraisal of Contemporary Clinical Endpoint Definitions in Coronary Intervention Trials: A Guidance Document. JACC Cardiovasc Interv. 2019 05 13; 12(9):805-819. PMID: 31072504.
      Citations: 1     Fields:    Translation:Humans
    26. Mani P, Puri R, Schwartz GG, Nissen SE, Shao M, Kastelein JJP, Menon V, Lincoff AM, Nicholls SJ. Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome: A Secondary Analysis of the VISTA-16 Trial. JAMA Cardiol. 2019 04 01; 4(4):314-320. PMID: 30840024.
      Citations: 14     Fields:    Translation:HumansCTClinical Trials
    27. Kumar A, Patel DR, Wolski KE, Lincoff AM, Kashyap SR, Ruotolo G, McErlean E, Weerakkody G, Riesmeyer JS, Nicholls SJ, Nissen SE, Menon V. Baseline fasting plasma insulin levels predict risk for major adverse cardiovascular events among patients with diabetes and high-risk vascular disease: Insights from the ACCELERATE trial. Diab Vasc Dis Res. 2019 03; 16(2):171-177. PMID: 31014095.
      Citations:    Fields:    Translation:Humans
    28. Menon V, Lincoff AM, Nicholls SJ, Jasper S, Wolski K, McGuire DK, Mehta CR, Rosenstock J, Lopez C, Marcinak J, Cao C, Nissen SE. Fasiglifam-Induced Liver Injury in Patients With Type 2 Diabetes: Results of a Randomized Controlled Cardiovascular Outcomes Safety Trial. Diabetes Care. 2018 12; 41(12):2603-2609. PMID: 30459247.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    29. Reed GW, Abdallah MS, Shao M, Wolski K, Wisniewski L, Yeomans N, Lüscher TF, Borer JS, Graham DY, Husni ME, Solomon DH, Libby P, Menon V, Lincoff AM, Nissen SE. Effect of Aspirin Coadministration on the Safety of Celecoxib, Naproxen, or Ibuprofen. J Am Coll Cardiol. 2018 04 24; 71(16):1741-1751. PMID: 29673465.
      Citations: 6     Fields:    Translation:Humans
    30. Ruschitzka F, Borer JS, Krum H, Flammer AJ, Yeomans ND, Libby P, Lüscher TF, Solomon DH, Husni ME, Graham DY, Davey DA, Wisniewski LM, Menon V, Fayyad R, Beckerman B, Iorga D, Lincoff AM, Nissen SE. Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) Trial. Eur Heart J. 2017 Nov 21; 38(44):3282-3292. PMID: 29020251.
      Citations: 16     Fields:    Translation:Humans
    31. Solomon DH, Husni ME, Libby PA, Yeomans ND, Lincoff AM, L?scher TF, Menon V, Brennan DM, Wisniewski LM, Nissen SE, Borer JS. The Risk of Major NSAID Toxicity with Celecoxib, Ibuprofen, or Naproxen: A Secondary Analysis of the PRECISION Trial. Am J Med. 2017 12; 130(12):1415-1422.e4. PMID: 28756267.
      Citations: 19     Fields:    Translation:Humans
    32. Reed GW, Horr S, Young L, Clevenger J, Malik U, Ellis SG, Lincoff AM, Nissen SE, Menon V. Associations Between Cardiac Troponin, Mechanism of Myocardial Injury, and Long-Term Mortality After Noncardiac Vascular Surgery. J Am Heart Assoc. 2017 Jun 06; 6(6). PMID: 28588090.
      Citations: 5     Fields:    Translation:HumansCells
    33. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 28729411.
      Citations: 5     Fields:    Translation:Humans
    34. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 28372804.
      Citations: 14     Fields:    Translation:Humans
    35. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 26541908.
      Citations: 16     Fields:    Translation:Humans
    36. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 30375246.
      Citations: 9     Fields:    Translation:Humans
    37. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 30879324.
      Citations: 24     Fields:    Translation:Humans
    38. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 31339509.
      Citations: 13     Fields:    Translation:HumansCTClinical Trials
    39. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 28514624.
      Citations: 150     Fields:    Translation:HumansCTClinical Trials
    40. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 29266879.
      Citations: 10     Fields:    Translation:Humans
    41. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 24156746.
      Citations: 2     Fields:    Translation:Humans
    42. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 32179516.
      Citations: 4     Translation:Humans
    43. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 31707801.
      Citations: 9     Fields:    Translation:Humans
    44. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 12871682.
      Citations: 1     Fields:    Translation:Humans
    45. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 15261929.
      Citations: 106     Fields:    Translation:Humans
    46. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 19028780.
      Citations: 8     Fields:    Translation:Humans
    47. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 19339264.
      Citations: 29     Fields:    Translation:Humans
    48. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 18573394.
      Citations: 9     Fields:    Translation:Humans
    49. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 22172242.
      Citations: 1     Fields:    Translation:Humans
    50. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 21320709.
      Citations: 11     Fields:    Translation:Humans
    51. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 23351464.
      Citations: 4     Fields:    Translation:Humans
    52. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 25399775.
      Citations: 12     Fields:    Translation:Humans
    53. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 23999933.
      Citations: 23     Fields:    Translation:Humans
    54. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 24815500.
      Citations: 30     Fields:    Translation:Humans
    55. Nissen SE, Yeomans ND, Solomon DH, Lüscher TF, Libby P, Husni ME, Graham DY, Borer JS, Wisniewski LM, Wolski KE, Wang Q, Menon V, Ruschitzka F, Gaffney M, Beckerman B, Berger MF, Bao W, Lincoff AM. Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis. N Engl J Med. 2016 12 29; 375(26):2519-29. PMID: 27959716.
      Citations: 158     Fields:    Translation:Humans
    56. Parashar A, Agarwal S, Krishnaswamy A, Sud K, Poddar KL, Bassi M, Ellis S, Tuzcu EM, Menon V, Kapadia SR. Percutaneous Intervention for Myocardial Infarction After Noncardiac Surgery: Patient Characteristics and Outcomes. J Am Coll Cardiol. 2016 07 26; 68(4):329-38. PMID: 27443427.
      Citations: 10     Fields:    Translation:Humans
    57. Mandsager K, Tan C, Menon V. Aspergillus prosthetic valve endocarditis. Eur Heart J. 2016 11 01; 37(41):3178. PMID: 27165628.
      Citations:    Fields:    Translation:HumansAnimals
    58. Shimada YJ, Cannon CP, Liu Y, Wilson C, Kupfer S, Menon V, Cushman WC, Mehta CR, Bakris GL, Zannad F, White WB. Ischemic cardiac outcomes and hospitalizations according to prior macrovascular disease status in patients with type 2 diabetes and recent acute coronary syndrome from the Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care trial. Am Heart J. 2016 May; 175:18-27. PMID: 27179720.
      Citations: 2     Fields:    Translation:Humans
    59. Aggarwal B, Shah GK, Randhawa M, Ellis SG, Lincoff AM, Menon V. Utility of Glycated Hemoglobin for Assessment of Glucose Metabolism in Patients With ST-Segment Elevation Myocardial Infarction. Am J Cardiol. 2016 Mar 01; 117(5):749-53. PMID: 26768673.
      Citations: 4     Fields:    Translation:Humans
    60. Hachamovitch R, Nutter B, Menon V, Cerqueira MD. Predicting Risk Versus Predicting Potential Survival Benefit Using 123I-mIBG Imaging in Patients With Systolic Dysfunction Eligible for Implantable Cardiac Defibrillator Implantation: Analysis of Data From the Prospective ADMIRE-HF Study. Circ Cardiovasc Imaging. 2015 Dec; 8(12). PMID: 26666380.
      Citations: 5     Fields:    Translation:Humans
    61. Agarwal S, Sud K, Martin JM, Menon V. Trends in the Use of Mechanical Circulatory Support Devices in Patients Presenting With ST-Segment Elevation Myocardial Infarction. JACC Cardiovasc Interv. 2015 Nov; 8(13):1772-4. PMID: 26585627.
      Citations: 9     Fields:    Translation:Humans
    62. Puri R, Nissen SE, Menon V, Shao M, Hsu A, Bakris GL, Kastelein JJ, Williams B, Armbrecht J, Brunel P, Kataoka Y, Nicholls SJ. Effects of aliskiren in diabetic and non-diabetic patients with coronary artery disease: Insights from AQUARIUS. Atherosclerosis. 2015 Dec; 243(2):553-9. PMID: 26523993.
      Citations: 2     Fields:    Translation:Humans
    63. Nicholls SJ, Lincoff AM, Barter PJ, Brewer HB, Fox KA, Gibson CM, Grainger C, Menon V, Montalescot G, Rader D, Tall AR, McErlean E, Riesmeyer J, Vangerow B, Ruotolo G, Weerakkody GJ, Nissen SE. Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: Rationale and design of the ACCELERATE trial. Am Heart J. 2015 Dec; 170(6):1061-9. PMID: 26678626.
      Citations: 21     Fields:    Translation:HumansCTClinical Trials
    64. Sperry BW, Jacob MS, Menon V, Soltesz EG, Rodriguez ER, Popovic ZB. Defying Dogma: Recovery After Left Ventricular Assist Device Implantation and Aortic Valve Replacement for Bicuspid Aortic Valve. Circ Heart Fail. 2015 Jul; 8(4):832-5. PMID: 26199310.
      Citations: 1     Fields:    Translation:Humans
    65. Agarwal S, Menon V, Jaber WA. Outcomes after acute ischemic stroke in the United States: does residential ZIP code matter? J Am Heart Assoc. 2015 Mar 15; 4(3):e001629. PMID: 25773298.
      Citations: 5     Fields:    Translation:Humans
    66. Aggarwal B, Raymond CE, Randhawa MS, Roselli E, Jacob J, Eagleton M, Kralovic DM, Kormos K, Holloway D, Menon V. Transfer metrics in patients with suspected acute aortic syndrome. Circ Cardiovasc Qual Outcomes. 2014 Sep; 7(5):780-2. PMID: 25205785.
      Citations: 2     Fields:    Translation:Humans
    67. Menon V, Lincoff AM. Cardiovascular safety evaluation in the development of new drugs for diabetes mellitus. Circulation. 2014 Jun 24; 129(25):2705-13. PMID: 24958753.
      Citations: 4     Fields:    Translation:Humans
    68. Nicholls SJ, Kastelein JJ, Schwartz GG, Bash D, Rosenson RS, Cavender MA, Brennan DM, Koenig W, Jukema JW, Nambi V, Wright RS, Menon V, Lincoff AM, Nissen SE. Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial. JAMA. 2014 Jan 15; 311(3):252-62. PMID: 24247616.
      Citations: 78     Fields:    Translation:Humans
    69. Inohara T, Kohsaka S, Fukuda K, Menon V. The challenges in the management of right ventricular infarction. Eur Heart J Acute Cardiovasc Care. 2013 Sep; 2(3):226-34. PMID: 24222834.
      Citations: 11     Fields:    Translation:Humans
    70. AlJaroudi WA, Alraies MC, Halley C, Menon V, Rodriguez LL, Grimm RA, Thomas JD, Jaber WA. Incremental prognostic value of diastolic dysfunction in low risk patients undergoing echocardiography: beyond Framingham score. Int J Cardiovasc Imaging. 2013 Oct; 29(7):1441-50. PMID: 23842890.
      Citations: 6     Fields:    Translation:Humans
    71. Cavender MA, Rajeswaran J, DiPaola L, Houghtaling P, Kiernan MS, Rassi AN, Menon V, Whitlow PW, Ellis SG, Shishehbor MH. Outcomes of culprit versus multivessel PCI in patients with multivessel coronary artery disease presenting with ST-elevation myocardial infarction complicated by shock. J Invasive Cardiol. 2013 May; 25(5):218-24. PMID: 23645045.
      Citations: 8     Fields:    Translation:Humans
    72. White HD, Reynolds HR, Carvalho AC, Pearte CA, Liu L, Martin CE, Knatterud GL, Džavík V, Kruk M, Steg PG, Cantor WJ, Menon V, Lamas GA, Hochman JS. Reinfarction after percutaneous coronary intervention or medical management using the universal definition in patients with total occlusion after myocardial infarction: results from long-term follow-up of the Occluded Artery Trial (OAT) cohort. Am Heart J. 2012 Apr; 163(4):563-71. PMID: 22520521.
      Citations: 18     Fields:    Translation:Humans
    73. Agarwal S, Hachamovitch R, Menon V. Current trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation: a meta-analysis. Arch Intern Med. 2012 Apr 23; 172(8):623-31; discussion 631-3. PMID: 22450212.
      Citations: 42     Fields:    Translation:HumansPHPublic Health
    74. Helton TJ, Nadig V, Subramanya SD, Menon V, Ellis SG, Shishehbor MH. Outcomes of cardiac catheterization and percutaneous coronary intervention for in-hospital ventricular tachycardia or fibrillation cardiac arrest. Catheter Cardiovasc Interv. 2012 Aug 01; 80(2):E9-14. PMID: 21735517.
      Citations:    Fields:    Translation:Humans
    75. Aksoy O, Yousefzai R, Singh D, Agarwal S, O'Brien B, Griffin BP, Kapadia SR, Tuzcu ME, Penn MS, Nissen SE, Menon V. Cardiogenic shock in the setting of severe aortic stenosis: role of intra-aortic balloon pump support. Heart. 2011 May; 97(10):838-43. PMID: 20962337.
      Citations: 4     Fields:    Translation:Humans
    76. Kruk M, Buller CE, Tcheng JE, Dzavík V, Menon V, Mancini GB, Forman SA, Kurray P, Busz-Papiez B, Lamas GA, Hochman JS. Impact of left ventricular ejection fraction on clinical outcomes over five years after infarct-related coronary artery recanalization (from the Occluded Artery Trial [OAT]). Am J Cardiol. 2010 Jan 01; 105(1):10-6. PMID: 20102883.
      Citations: 3     Fields:    Translation:Humans
    77. Krishnaswamy A, Lincoff AM, Menon V. Magnitude and consequences of missing the acute infarct-related circumflex artery. Am Heart J. 2009 Nov; 158(5):706-12. PMID: 19853686.
      Citations: 6     Fields:    Translation:Humans
    78. Cohen MG, Filby SJ, Roe MT, Chen AY, Menon V, Stouffer GA, Gibler WB, Smith SC, Pollack CV, Peterson ED, Ohman EM. The paradoxical use of cardiac catheterization in patients with non-ST-elevation acute coronary syndromes: lessons from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC /AHA Guidelines (CRUSADE) Quality Improvement Initiative. Am Heart J. 2009 Aug; 158(2):263-70. PMID: 19619704.
      Citations: 14     Fields:    Translation:Humans
    79. Cantor WJ, Baptista SB, Srinivas VS, Pearte CA, Menon V, Sadowski Z, Ross JR, Meciar P, Nikolsky E, Forman SA, Lamas GA, Hochman JS. Impact of stress testing before percutaneous coronary intervention or medical management on outcomes of patients with persistent total occlusion after myocardial infarction: analysis from the occluded artery trial. Am Heart J. 2009 Apr; 157(4):666-72. PMID: 19332193.
      Citations: 1     Fields:    Translation:Humans
    80. Kohsaka S, Menon V, Iwata K, Lowe A, Sleeper LA, Hochman JS. Microbiological profile of septic complication in patients with cardiogenic shock following acute myocardial infarction (from the SHOCK study). Am J Cardiol. 2007 Mar 15; 99(6):802-4. PMID: 17350369.
      Citations: 4     Fields:    Translation:HumansCells
    81. Gibson CM, Kirtane AJ, Murphy SA, Rohrbeck S, Menon V, Lins J, Kazziha S, Rokos I, Shammas NW, Palabrica TM, Fish P, McCabe CH, Braunwald E. Early initiation of eptifibatide in the emergency department before primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results of the Time to Integrilin Therapy in Acute Myocardial Infarction (TITAN)-TIMI 34 trial. Am Heart J. 2006 Oct; 152(4):668-75. PMID: 16996831.
      Citations: 14     Fields:    Translation:Humans
    82. Kohsaka S, Menon V, Lowe AM, Lange M, Dzavik V, Sleeper LA, Hochman JS. Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock. Arch Intern Med. 2005 Jul 25; 165(14):1643-50. PMID: 16043684.
      Citations: 49     Fields:    Translation:Humans
    83. Dzavik V, Sleeper LA, Picard MH, Sanborn TA, Lowe AM, Gin K, Saucedo J, Webb JG, Menon V, Slater JN, Hochman JS. Outcome of patients aged >or=75 years in the SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK (SHOCK) trial: do elderly patients with acute myocardial infarction complicated by cardiogenic shock respond differently to emergent revascularization? Am Heart J. 2005 Jun; 149(6):1128-34. PMID: 15976798.
      Citations: 9     Fields:    Translation:Humans
    84. Menon V, Harrington RA, Hochman JS, Cannon CP, Goodman SD, Wilcox RG, Schünemann HJ, Ohman EM. Thrombolysis and adjunctive therapy in acute myocardial infarction: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004 Sep; 126(3 Suppl):549S-575S. PMID: 15383484.
      Citations: 14     Fields:    Translation:HumansPHPublic Health
    85. Lee MS, Menon V, Schappert J, Wilentz JR, Singh V, Hochman JS. Establishing a new target range for unfractionated heparin for acute coronary syndromes. J Thromb Thrombolysis. 2004 Apr; 17(2):121-6. PMID: 15306747.
      Citations:    Fields:    Translation:Humans
    86. Srichai MB, Jaber WA, Prior DL, Marso SP, Houghtaling PL, Menon V, Simoons ML, Harrington RA, Hochman JS. Evaluating the benefits of glycoprotein IIb/IIIa inhibitors in heart failure at baseline in acute coronary syndromes. Am Heart J. 2004 Jan; 147(1):84-90. PMID: 14691424.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    87. Menon V, Hochman JS. Management of cardiogenic shock complicating acute myocardial infarction. Heart. 2002 Nov; 88(5):531-7. PMID: 12381652.
      Citations: 11     Fields:    Translation:Humans
    88. Lee MS, Wali AU, Menon V, Berkowitz SD, Thompson TD, Califf RM, Topol EJ, Granger CB, Hochman JS. The determinants of activated partial thromboplastin time, relation of activated partial thromboplastin time to clinical outcomes, and optimal dosing regimens for heparin treated patients with acute coronary syndromes: a review of GUSTO-IIb. J Thromb Thrombolysis. 2002 Oct; 14(2):91-101. PMID: 12714828.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    MENON's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (353)
    Explore
    _
    Co-Authors (4)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _